Articles

Results 6 to 10 of 19


CRISPR Update - July 2016

USA - July 29 2016 This is the first update on CRISPR, following on from our June 24 web conference entitled, "Navigating the CRISPR Patent Landscape and Business…

Tianran Yan

The PRICED Act Would Expedite Biosimilar Market Entry

USA - July 12 2016 Although the 12-year exclusivity period for original biologic products was a heavily negotiated provision of the Biologics Price Competition and…

Courtenay C. Brinckerhoff, Jason L. Drori, David L. Rosen

The PRICED Act Would Expedite Biosimilar Market Entry

USA - July 12 2016 Although the 12-year exclusivity period for original biologic products was a heavily negotiated provision of the Biologics Price Competition and…

Courtenay C. Brinckerhoff, Jason L. Drori, David L. Rosen

Are Drug Prices Really Too High?

USA - May 5 2016 Those working in the pharmaceutical space are used to hearing complaints about the high costs of drugs, and patents often are blamed for allowing…

Federal Circuit Backs PTAB Decision Curtailing A Party's Use Of "Supplemental" Information

USA - January 7 2016 In Redline Detection v. Star Envirotech, the Federal Circuit confirmed that the PTAB can decline to consider timely filed "supplemental" information…

Stephen B. Maebius